Cysteine metabolic engineering and selective disulfide reduction produce superior antibody-drug-conjugates.
Sci Rep
; 12(1): 7262, 2022 05 04.
Article
in En
| MEDLINE
| ID: mdl-35508689
Full text:
1
Database:
MEDLINE
Main subject:
Immunoconjugates
/
Antineoplastic Agents
Limits:
Animals
Language:
En
Journal:
Sci Rep
Year:
2022
Type:
Article
Affiliation country:
United States